iTrack™ Advance brings canaloplasty to both glaucoma and cataract surgeons with a repeatable and flexible workflow. Surgeons navigate Schlemm’s canal using an illuminated microcatheter tip for transscleral visualization, then deliver pressurized viscoelastic—without tearing tissue, and without leaving implants behind.
Featuring Shear Clear™ Technology, iTrack™ Advance creates shear forces that temporarily reduce viscoelastic viscosity during delivery, supporting distribution through Schlemm’s canal and into collector channels during a full 360° pass.
Catheterization plus pressurized viscodilation across the full 360° of the conventional outflow pathway, supporting a comprehensive canaloplasty approach.
Engineered and precision-crafted in our state-of-the-art facilities
Built on the established iTrack™ platform, with clinical evidence supporting long-term effectiveness and real-world adoption. (1), (2)
The best part about the iTrack™Advance is that it’s a simple, straightforward procedure where I can catheterize the entire canal from one site, in one direction, with a lit microcatheter that enables me to see exactly where I am.
J. Morgan Micheletti, MD, FACS (USA)
I love the iTrack™Advance for many reasons. I like that the handpiece has a single slider, so you can push from one end to the other and deploy the entire catheter with one push of one finger. It's just one smooth push. I also love the illuminated tip.
Mary Qiu, MD (USA)
Not only does iTrack™ Advance break the herniations in the canal, but it also viscodilates. So, it's flushing out the entire distal channel and also opening up the trabecular meshwork.
I. Paul Singh, MD (USA)
The illuminated tip is operating with a safety net. You always know the location of your microcatheter at any given time—and that is just better than having to guess where it is in the eye.
Rachel Gartell-Simpson, MD (USA)
iTrack™ Advance brings together illumination, pressurized viscoelastic delivery and surgeon-driven ergonomics to support a canaloplasty workflow built for control and repeatability while working with the eye’s natural outflow physiology.
Ultimately, it’s canaloplasty
without compromise.
*In-house bench testing data using a proprietary optical rheology test apparatus to assess the change in viscosity over time during viscoelastic delivery with the iTrack™ Advance. Bench testing data may not be indicative of clinical outcomes. Clinical effects depend on anatomy and surgical technique. Results may vary.
Nova Eye Medical, equips your surgeons with the best equipment for a non-destructive, long-term, patient care focused solution.
The iTrack™ Advance has a CE Mark (Conformité Européenne) 2862 and US Food and Drug Administration (FDA) 510(k) #K221872 for the treatment of open-angle glaucoma.
INDICATIONS (International): The iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. The iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open angle glaucoma.
CONTRAINDICATIONS (International): The iTrack™ Advance is not intended to be used for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in eyes of patients with the following conditions: Neovascular glaucoma; Angle-closure glaucoma; Previous surgery with resultant scarring of Schlemm’s canal.
ADVERSE EVENTS (International): Possible adverse events with the use of the iTrack™ Advance include, but are not limited to: hyphema, elevated IOP, Descemet’s membrane detachment, shallow or flat anterior chamber, hypotony, trabecular meshwork rupture, choroidal effusion, Peripheral Anterior Synechiae (PAS) and iris prolapse.
PRECAUTIONS (International): The iTrack™ Advance should be used only by physicians trained in ophthalmic surgery. Knowledge of surgical techniques, proper use of the surgical instruments, and post-operative patient management are considerations essential to a successful outcome.
For full safety information, visit: https://itrack-advance.com
© 2026. Nova Eye, Inc. E&OE. Patents pending and/orgranted.
iTrack™ Advance, iTrack™, ViscoInjector™ and iLumin™ are trademarks of Nova Eye,Inc.
